WARPTECHNEWS · LAB

Home AI Business Tech Archive

WARPTECH NEWS· by Warptech Lab

© 2026120+ international sourcesupdated hourly

Storia: Wegovy maker Novo Nordisk warns of slower profits as rivals bite — Warptech News

Storia in 5 fonti

Wegovy maker Novo Nordisk warns of slower profits as rivals bite

The Danish weight loss drug-maker claims "knock-off" treatments are hitting growth.

Raccontata da

cincodias.elpais.com

martedì 29 luglio 2025·cincodias.elpais.com
Novo Nordisk se desploma en Bolsa tras reducir de nuevo sus previsiones sobre Ozempic y Wegovy para este año
La farmacéutica danesa espera un crecimiento menor, lo que supone su segundo recorte de estimaciones en lo que va de año
martedì 29 luglio 2025·cnbc.com
Novo Nordisk shares plunge after Wegovy maker names new CEO, cuts full-year guidance
Danish pharmaceutical giant Novo Nordisk on Tuesday cut its full-year sales and profit guidance.

martedì 29 luglio 2025·

bbc.com

Wegovy maker Novo Nordisk warns of slower profits as rivals bite

The Danish weight loss drug-maker claims "knock-off" treatments are hitting growth.

martedì 29 luglio 2025·

npr.org

Drugmaker Novo Nordisk slashes Wegovy sales forecasts, blaming compounding

Compounding pharmacies are crimping sales of Novo Nordisk's obesity drug Wegovy by making what are essentially copies of the name-brand medicine. The company says it trying to…

mercoledì 30 luglio 2025·

corriere.it

Crollo di Novo Nordisk, la concorrenza e le strategie di prezzo mettono a rischio il colosso dei farmaci per la perdita di peso

Nuovo tonfo alla borsa di Copenaghen per il gigante danese. A contribuire all'incertezza degli investitori il cambio al vertice e l'ingresso di nuovi competitor

mercoledì 30 luglio 2025·

cnbc.com

Novo Nordisk gets a downgrade from Bank of America as Wegovy growth outlook weakens

The bank downgraded the Danish pharmaceutical giant to neutral from buy and decreased its price target.